Brief: Lonza Expands Strategic Collaboration With Leading Us Biopharmaceutical Company
BRIEF-Lonza Expands Strategic Collaboration With Leading Us Biopharmaceutical Company July 1 (Reuters) - LONZA GROUP AG LONN.S:
LONZA EXPANDS STRATEGIC COLLABORATION WITH LEADING US BIOPHARMACEUTICAL COMPANY
ANNOUNCES EXPANDED STRATEGIC COLLABORATION WITH LEADING US BIOPHARMACEUTICAL COMPANY
COLLABORATION HAS POTENTIAL TO DELIVER MULTI-BILLION CHF CUMULATIVE VALUE
EXPANSION ADDS TWO COMMERCIAL BIOLOGICS PROGRAMS WITH OPTION FOR TWO MORE
Source text: ID:nEQ60lSF4a
Further company coverage: LONN.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lonza AG
See all newsLonza buys 5 sites from Germany's Merck to more than double US footprint (updated)
Brief: Merck KGaA Confirms Divestment Of CDMO Business To Lonza
Lonza agrees to buy five US sites from Merck KGaA
Corrected: TABLE-Swiss trade surplus at CHF 4.35 bln in August (Sept. 17)
Table: Swiss trade surplus at CHF 1.31 bln in September